Unravelling the mystery of a rare infection: a challenging case of pulmonary sequestration with Mycobacterium avium complex and the importance of a thorough microbiological investigation

BMJ Case Rep. 2023 Sep 12;16(9):e255346. doi: 10.1136/bcr-2023-255346.

Abstract

Pulmonary sequestration is a rare congenital condition. It is a dysplastic lung tissue with a separate systemic blood supply and without a bronchial tree connection. The emergence of a superimposed infection can lead to its diagnosis, such as Staphylococcus aureus, Pseudomonas aeruginosa, Nocardia asteroids and Aspergillus sp pneumonia. Mycobacterium avium complex (MAC) superimposed disease is exceedingly rare. We report a case of a man in his third decade without known medical disorders presenting with a persistent cough. After an extensive microbiological workup, an MAC infection was diagnosed. An elevated carbohydrate antigen 19-9 (CA 19-9) was also noted. He was treated with antimycobacterial therapy and lobectomy resulting in clinical improvement and CA19-9 normalisation. This case illustrates the value of comprehensive microbiological investigations in patients with chronic respiratory symptoms and imaging findings that are not typical of bacterial pneumonia. Clinical studies remain needed to investigate the utility of CA 19-9 in a scoring system to guide MAC therapy.

Keywords: Congenital disorders; Infections; Pneumonia (infectious disease); Pneumonia (respiratory medicine); TB and other respiratory infections.

Publication types

  • Case Reports

MeSH terms

  • Aspergillosis*
  • Bronchopulmonary Sequestration* / diagnosis
  • Bronchopulmonary Sequestration* / diagnostic imaging
  • CA-19-9 Antigen
  • Humans
  • Male
  • Mycobacterium avium Complex
  • Mycobacterium avium-intracellulare Infection* / complications
  • Mycobacterium avium-intracellulare Infection* / diagnosis
  • Mycobacterium avium-intracellulare Infection* / drug therapy
  • Rare Diseases

Substances

  • CA-19-9 Antigen